StockData
Oscar Health, Inc. logo

Oscar Health, Inc. (OSCR) stock

OSCRNYSEHospital & Medical Service PlansFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3028% above fair value
$31.33+0.28 (+0.90%)

Close on Nov 16, 2026Market cap $9.67BP/E 22.4Yield –

Oscar Health ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Oscar Health's ebitda for the twelve months ending Jun 30, 2026 was $657.96M. For fiscal 2025 it was -$367.47M, down 511.0% from the year before. The highest annual figure on record is $89.41M in fiscal 2024.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$367.47M-511.0%
FY2024Dec 31, 2024$89.41M–
FY2023Dec 31, 2023-$204.92M–
FY2022Dec 31, 2022-$574.58M–
FY2021Dec 31, 2021-$529.88M–
FY2020Dec 31, 2020-$390.98M–
FY2019Dec 31, 2019-$252.49M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$394.67M–
Q1 FY2026Mar 31, 2026$711.10M+134.0%
Q4 FY2025Dec 31, 2025-$325.87M–
Q3 FY2025Sep 30, 2025-$121.94M–
Q2 FY2025Jun 30, 2025-$223.51M-396.4%
Q1 FY2025Mar 31, 2025$303.85M+57.1%
Q4 FY2024Dec 31, 2024-$138.50M–
Q3 FY2024Sep 30, 2024-$40.87M–
Q2 FY2024Jun 30, 2024$75.41M+3188.8%
Q1 FY2024Mar 31, 2024$193.37M–
Q4 FY2023Dec 31, 2023-$137.74M–
Q3 FY2023Sep 30, 2023-$49.05M–
Q2 FY2023Jun 30, 2023$2.29M–
Q1 FY2023Mar 31, 2023-$20.43M–
Q4 FY2022Dec 31, 2022-$218.74M–
Q3 FY2022Sep 30, 2022-$188.31M–
Q2 FY2022Jun 30, 2022-$102.80M–
Q1 FY2022Mar 31, 2022-$64.73M–
Q4 FY2021Dec 31, 2021-$192.28M–
Q3 FY2021Sep 30, 2021-$208.04M–
Q2 FY2021Jun 30, 2021-$68.92M–
Q1 FY2021Mar 31, 2021-$60.64M–
Q4 FY2020Dec 31, 2020-$183.54M–
Q3 FY2020Sep 30, 2020-$77.21M–
Q2 FY2020Jun 30, 2020-$36.83M–
Q1 FY2020Mar 31, 2020-$93.40M–

More Oscar Health figures

See a number that looks wrong?